Chemotherapy Resistance Status of Common Human Pathogenic Protozoa

1.Adam R.D.: Giardia duodenalis: Biology and Pathogenesis. Clinical Microbiology Reviews. 34(4), e00024–19 (2021) doi: 10.1128/CMR.00024-19 AdamR.D. Giardia duodenalis: Biology and Pathogenesis Clinical Microbiology Reviews. 34 4 e00024–19 2021 10.1128/CMR.00024-19Open DOI

2.Alday P.H., Bruzual I., Nilsen A., Pou S., Winter R., Ben Mamoun C., Riscoe M.K., Doggett J.S.: Genetic Evidence for Cytochrome b Qi Site Inhibition by 4(1H)-Quinolone-3-Diarylethers and Antimycin in Toxoplasma gondii. Antimicrob Agents Chemother. 61(2) e01866–16 (2017) doi: 10.1128/AAC.01866-16 AldayP.H. BruzualI. NilsenA. PouS. WinterR. Ben MamounC. RiscoeM.K. DoggettJ.S. Genetic Evidence for Cytochrome b Qi Site Inhibition by 4(1H)-Quinolone-3-Diarylethers and Antimycin in Toxoplasma gondii Antimicrob Agents Chemother 61 2 e01866–16 2017 10.1128/AAC.01866-16Open DOI

3.Allain T., Amat C.B., Motta J.P., Manko A., Buret A.G.: Interactions of Giardia sp. with the intestinal barrier: Epithelium, mucus, and microbiota. Tissue Barriers. 5(1), e1274354 (2017) doi: 10.1080/21688370.2016.1274354 AllainT. AmatC.B. MottaJ.P. MankoA. BuretA.G. Interactions of Giardia sp. with the intestinal barrier: Epithelium, mucus, and microbiota Tissue Barriers. 5 1 e1274354 2017 10.1080/21688370.2016.1274354Open DOI

4.Alshahethi M.A., Al-Hadheq A.A., Edrees W.H., Abdullah Q.Y., Al-Awar M.S.: Cutaneous leishmaniasis among attending hospitals and health centers in amran governorate, yemen. Electronic Journal of University of Aden for Basic and Applied Sciences. 5(3) 269–276 (2024) doi: 10.47372/ejua-ba.2024.3.373 AlshahethiM.A. Al-HadheqA.A. EdreesW.H. AbdullahQ.Y. Al-AwarM.S. Cutaneous leishmaniasis among attending hospitals and health centers in amran governorate, yemen Electronic Journal of University of Aden for Basic and Applied Sciences 5 3 269 276 2024 10.47372/ejua-ba.2024.3.373Open DOI

5.Amelo W. and Makonnen E.: Efforts Made to Eliminate Drug-Resistant Malaria and Its Challenges. BioMed Research International. 2021(1), 5539544 (2021) doi: 10.1155/2021/5539544 AmeloW. MakonnenE. Efforts Made to Eliminate Drug-Resistant Malaria and Its Challenges BioMed Research International 2021 1 5539544 2021 10.1155/2021/5539544Open DOI

6.Andriantsoanirina V., Khim N., Ratsimbasoa A., Witkowski B., Benedet C., Canier L., Bouchier C., Tichit M., Durand R., Ménard D.: Plasmodium falciparum Na+/H+ Exchanger (pfnhe-1) Genetic Polymorphism in Indian Ocean Malaria-Endemic Areas. The American Journal of Tropical Medicine and Hygiene. 88(1), 37 (2013) doi: 10.4269/ajtmh.2012.12-0359 AndriantsoanirinaV. KhimN. RatsimbasoaA. WitkowskiB. BenedetC. CanierL. BouchierC. TichitM. DurandR. MénardD. Plasmodium falciparum Na+/H+ Exchanger (pfnhe-1) Genetic Polymorphism in Indian Ocean Malaria-Endemic Areas The American Journal of Tropical Medicine and Hygiene 88 1 37 2013 10.4269/ajtmh.2012.12-0359Open DOI

7.Ángeles-Arvizu A., Enriquez-Flores S., Jiménez-Gutiérrez A., Pérez-Rangel A., Luna-Arias J.P., Castillo-Romero A., Hernández J.M., León-Avila G.: MDR1 protein (ABC-C1) Over Expression in Giardia Intestinalis Incubated with Albendazole and Nitazoxanide. Acta Parasit. 66(4) 1158–1166 (2021) doi: 10.1007/s11686-021-00385-5 Ángeles-ArvizuA. Enriquez-FloresS. Jiménez-GutiérrezA. Pérez-RangelA. Luna-AriasJ.P. Castillo-RomeroA. HernándezJ.M. León-AvilaG. MDR1 protein (ABC-C1) Over Expression in Giardia Intestinalis Incubated with Albendazole and Nitazoxanide Acta Parasit 66 4 1158 1166 2021 10.1007/s11686-021-00385-5Open DOI

8.Argüello-García R., Cruz-Soto M., González-Trejo R., Paz-Maldonado L.M.T., Bazán-Tejeda M.L., Mendoza-Hernández G., Ortega-Pierres G.: An antioxidant response is involved in resistance of Giardia duodenalis to albendazole. Front Microbiol. 6, 286 (2015) doi: 10.3389/fmicb.2015.00286 Argüello-GarcíaR. Cruz-SotoM. González-TrejoR. Paz-MaldonadoL.M.T. Bazán-TejedaM.L. Mendoza-HernándezG. Ortega-PierresG. An antioxidant response is involved in resistance of Giardia duodenalis to albendazole Front Microbiol 6 286 2015 10.3389/fmicb.2015.00286Open DOI

9.Asare K.K., Africa J., Mbata J., Opoku Y.K.: The emergence of chloroquine-sensitive Plasmodium falciparum is influenced by selected communities in some parts of the Central Region of Ghana. Malar. J. 20(1) 447 (2021) doi: 10.1186/s12936-021-03985-8 AsareK.K. AfricaJ. MbataJ. OpokuY.K. The emergence of chloroquine-sensitive Plasmodium falciparum is influenced by selected communities in some parts of the Central Region of Ghana Malar. J 20 1 447 2021 10.1186/s12936-021-03985-8Open DOI

10.Avcı K.D., Karakuş M., Kart Yaşar K.: Molecular survey of pfmdr-1, pfcrt, and pfk13 gene mutations among patients returning from Plasmodium falciparum endemic areas to Turkey. Malar J. 23(1) 286 (2024) doi: 10.1186/s12936-024-05107-6. AvcıK.D. KarakuşM. Kart YaşarK. Molecular survey of pfmdr-1, pfcrt, and pfk13 gene mutations among patients returning from Plasmodium falciparum endemic areas to Turkey Malar J 23 1 286 2024 10.1186/s12936-024-05107-6Open DOI

11.Babokhov P., Sanyaolu A.O., Oyibo W.A., Fagbenro-Beyioku A.F., Iriemenam N.C.: A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis. Pathogens and Global Health. 107(5) 242–252 (2013) doi: 10.1179/2047773213Y.0000000105 BabokhovP. SanyaoluA.O. OyiboW.A. Fagbenro-BeyiokuA.F. IriemenamN.C. A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis Pathogens and Global Health 107 5 242 252 2013 10.1179/2047773213Y.0000000105Open DOI

12.Baina M.T., Djontu J.C., Mbama Ntabi J.D., Mfoutou Mapanguy C.C., Lissom A., Vouvoungui C.J., Boumpoutou R.K., Mouanga A.M., Nguimbi E., Ntoumi F.: Polymorphisms in the Pfcrt, Pfmdr1, and Pfk13 genes of Plasmodium falciparum isolates from southern Brazzaville, Republic of Congo. Sci Rep. 14(1), 27988 (2024) doi: 10.1038/s41598-024-78670-2 BainaM.T. DjontuJ.C. Mbama NtabiJ.D. Mfoutou MapanguyC.C. LissomA. VouvounguiC.J. BoumpoutouR.K. MouangaA.M. NguimbiE. NtoumiF. Polymorphisms in the Pfcrt, Pfmdr1, and Pfk13 genes of Plasmodium falciparum isolates from southern Brazzaville, Republic of Congo Sci Rep 14 1 27988 2024 10.1038/s41598-024-78670-2Open DOI

13.Balaji S.N., Deshmukh R., Trivedi V.: Severe malaria: Biology, clinical manifestation, pathogenesis and consequences. Journal of Vector Borne Diseases. 57(1) 1 (2020) doi: 10.4103/0972-9062.308793 BalajiS.N. DeshmukhR. TrivediV. Severe malaria: Biology, clinical manifestation, pathogenesis and consequences Journal of Vector Borne Diseases 57 1 1 2020 10.4103/0972-9062.308793Open DOI

14.Berberian D.A.: Treatment and prophylaxis of malaria with aralen. J Palest Arab Med Assoc. 2(6) 143–151 (1947) BerberianD.A. Treatment and prophylaxis of malaria with aralen J Palest Arab Med Assoc 2 6 143 151 1947 Search in Google Scholar

15.Bisetegn H., Zeleke A.J., Gadisa E., Shumie G., Damte D., Fenta T., Behaksra S., Bayih A.G.: Clinical, parasitological and molecular profiles of Cutaneous Leishmaniasis and its associated factors among clinically suspected patients attending Borumeda Hospital, North-East Ethiopia. PLoS Negl Trop Dis. 14(8) e0008507 (2020) doi: 10.1371/journal.pntd.0008507 BisetegnH. ZelekeA.J. GadisaE. ShumieG. DamteD. FentaT. BehaksraS. BayihA.G. Clinical, parasitological and molecular profiles of Cutaneous Leishmaniasis and its associated factors among clinically suspected patients attending Borumeda Hospital, North-East Ethiopia PLoS Negl Trop Dis 14 8 e0008507 2020 10.1371/journal.pntd.0008507Open DOI

16.Black M.W. and Boothroyd J.C.: Lytic Cycle of Toxoplasma gondii. Microbiol Mol Biol Rev. 64(3) 607–623 (2000) doi: 10.1128/MMBR.64.3.607-623.2000 BlackM.W. BoothroydJ.C. Lytic Cycle of Toxoplasma gondii Microbiol Mol Biol Rev. 64 3 607 623 2000 10.1128/MMBR.64.3.607-623.2000Open DOI

17.Bogacz J.: 1954. [Comparative effect of various synthetic agents and various antibiotics, including spiramycin, on Toxoplasma]. Bull Soc Pathol Exot Filiales. 47(6) 903–915 BogaczJ. 1954 [Comparative effect of various synthetic agents and various antibiotics, including spiramycin, on Toxoplasma] Bull Soc Pathol Exot Filiales 47 6 903 915 Search in Google Scholar

18.Bouteille B., Oukem O., Bisser S., Dumas M.: Treatment perspectives for human African trypanosomiasis. Fundamental & Clinical Pharmacology. 17(2) 171–181 (2003) doi: 10.1046/j.1472-8206.2003.00167.x BouteilleB. OukemO. BisserS. DumasM. Treatment perspectives for human African trypanosomiasis Fundamental & Clinical Pharmacology 17 2 171 181 2003 10.1046/j.1472-8206.2003.00167.xOpen DOI

19.Bridges D.J., Gould M.K., Nerima B., Mäser P., Burchmore R.J.S., Koning H.P.: Loss of the High-Affinity Pentamidine Transporter Is Responsible for High Levels of Cross-Resistance between Arsenical and Diamidine Drugs in African Trypanosomes. Mol Pharmacol. 71(4) 1098–1108 (2007) doi: 10.1124/mol.106.031351 BridgesD.J. GouldM.K. NerimaB. MäserP. BurchmoreR.J.S. KoningH.P. Loss of the High-Affinity Pentamidine Transporter Is Responsible for High Levels of Cross-Resistance between Arsenical and Diamidine Drugs in African Trypanosomes Mol Pharmacol. 71 4 1098 1108 2007 10.1124/mol.106.031351Open DOI

20.Büscher P., Cecchi G., Jamonneau V., Priotto G.: Human African trypanosomiasis. Lancet. 390(10110) 2397–2409 (2017) doi: 10.1016/S0140-6736(17)31510-6 BüscherP. CecchiG. JamonneauV. PriottoG. Human African trypanosomiasis Lancet. 390 10110 2397 2409 2017 10.1016/S0140-6736(17)31510-6Open DOI

21.Camuset G., Remy V., Hansmann Y., Christmann D., Gomes de Albuquerque C., Sena Casseb G.A.: [Mucocutaneous leishmaniasis in Brazilian Amazonia]. Med Mal Infect. 37(6) 343–346 (2007) doi: 10.1016/j.medmal.2007.03.012. CamusetG. RemyV. HansmannY. ChristmannD. Gomes de AlbuquerqueC. Sena CassebG.A. [Mucocutaneous leishmaniasis in Brazilian Amazonia] Med Mal Infect. 37 6 343 346 2007 10.1016/j.medmal.2007.03.012Open DOI

22.Carnielli J.B.T., Monti-Rocha R., Costa D.L., Molina Sesana A., Pansini L.N.N., Segatto M., Mottram J.C., Costa C.H.N., Carvalho S.F.G., Dietze R.: Natural Resistance of Leishmania infantum to miltefosine Contributes to the Low Efficacy in the Treatment of Visceral Leishmaniasis in Brazil. Am J Trop Med Hyg. 101(4) 789–794 (2019) doi: 10.4269/ajtmh.18-0949 CarnielliJ.B.T. Monti-RochaR. CostaD.L. Molina SesanaA. PansiniL.N.N. SegattoM. MottramJ.C. CostaC.H.N. CarvalhoS.F.G. DietzeR. Natural Resistance of Leishmania infantum to miltefosine Contributes to the Low Efficacy in the Treatment of Visceral Leishmaniasis in Brazil Am J Trop Med Hyg. 101 4 789 794 2019 10.4269/ajtmh.18-0949Open DOI

23.CDC. 2019. CDC – DPDx – Amebiasis. https://www.cdc.gov/dpdx/amebiasis/index.html. [accessed 2024 Aug 27] CDC 2019 CDC – DPDx – Amebiasis https://www.cdc.gov/dpdx/amebiasis/index.html. [accessed 2024 Aug 27] Search in Google Scholar

24.CDC. 2024a. CDC – DPDx – Malaria. https://www.cdc.gov/dpdx/malaria/index.html. [accessed 2024 Aug 26] CDC 2024a CDC – DPDx – Malaria https://www.cdc.gov/dpdx/malaria/index.html. [accessed 2024 Aug 26] Search in Google Scholar

25.CDC. 2024b. Appendix A: Malaria in the United States: Treatment Tables. Malaria. https://www.cdc.gov/malaria/hcp/clinical-guidance/malaria-treatment-tables.html. [accessed 2024 Sep 7] CDC 2024b Appendix A: Malaria in the United States: Treatment Tables. Malaria https://www.cdc.gov/malaria/hcp/clinical-guidance/malaria-treatment-tables.html. [accessed 2024 Sep 7] Search in Google Scholar

26.CDC. 2024c. About Toxoplasmosis. Toxoplasmosis. https://www.cdc.gov/toxoplasmosis/about/index.html. [accessed 2024 Sep 15] CDC 2024c About Toxoplasmosis. Toxoplasmosis https://www.cdc.gov/toxoplasmosis/about/index.html. [accessed 2024 Sep 15] Search in Google Scholar

27.CDC. 2024d. Clinical Care of Human African Trypanosomiasis. Sleeping Sickness (African Trypanosomiasis). https://www.cdc.gov/sleeping-sickness/hcp/clinical-care/index.html [accessed 2024 Sep 9] CDC 2024d Clinical Care of Human African Trypanosomiasis. Sleeping Sickness (African Trypanosomiasis) https://www.cdc.gov/sleeping-sickness/hcp/clinical-care/index.html [accessed 2024 Sep 9] Search in Google Scholar

28.CDC. 2024e. Patient Care for Giardia Infection. Giardia. https://www.cdc.gov/giardia/hcp/clinical-care/index.html. [accessed 2024 Sep 15] CDC 2024e Patient Care for Giardia Infection. Giardia https://www.cdc.gov/giardia/hcp/clinical-care/index.html. [accessed 2024 Sep 15] Search in Google Scholar

29.Cernikova L., Faso C., Hehl A.B.: Five facts about Giardia lamblia. PLOS Pathogens. 14(9) e1007250 (2018) doi: 10.1371/journal.ppat.1007250 CernikovaL. FasoC. HehlA.B. Five facts about Giardia lamblia PLOS Pathogens 14 9 e1007250 2018 10.1371/journal.ppat.1007250 Open DOI

30.Certad G., Viscogliosi E., Chabé M., Cacciò S.M.: Pathogenic Mechanisms of Cryptosporidium and Giardia. Trends in Parasitology. 33(7) 561–576 (2017) doi: 10.1016/j.pt.2017.02.006 CertadG. ViscogliosiE. ChabéM. CacciòS.M. Pathogenic Mechanisms of Cryptosporidium and Giardia Trends in Parasitology. 33 7 561 576 2017 10.1016/j.pt.2017.02.006 Open DOI

31.Ciuca L., Pepe P., Bosco A., Caccio S.M., Maurelli M.P., Sannella A.R., Vismarra A., Cringoli G., Kramer L., Rinaldi L., et al. Effectiveness of Fenbendazole and Metronidazole Against Giardia Infection in Dogs Monitored for 50-Days in Home-Conditions. Front Vet Sci. 8 626424 (2021) doi: 10.3389/fvets.2021.626424 CiucaL. PepeP. BoscoA. CaccioS.M. MaurelliM.P. SannellaA.R. VismarraA. CringoliG. KramerL. RinaldiL. Effectiveness of Fenbendazole and Metronidazole Against Giardia Infection in Dogs Monitored for 50-Days in Home-Conditions Front Vet Sci 8 626424 2021 10.3389/fvets.2021.626424 Open DOI

32.Cowell A.N., Winzeler E.A.: The genomic architecture of anti-malarial drug resistance. Brief Funct Genomics. 18(5) 314–328 (2019) doi: 10.1093/bfgp/elz008 CowellA.N. WinzelerE.A. The genomic architecture of anti-malarial drug resistance Brief Funct Genomics. 18 5 314 328 2019 10.1093/bfgp/elz008 Open DOI

33.Cui Z., Li J., Chen Y., Zhang L.: Molecular epidemiology, evolution, and phylogeny of Entamoeba spp. Infection, Genetics and Evolution. 75, 104018 (2019) doi: 10.1016/j.meegid.2019.104018 CuiZ. LiJ. ChenY. ZhangL. Molecular epidemiology, evolution, and phylogeny of Entamoeba spp Infection, Genetics and Evolution 75 104018 2019 10.1016/j.meegid.2019.104018 Open DOI

34.Dama S., Diakite B., Dinkorma O.T., Niangaly A., Kone A.K., Dara A., Kone A., Bamadio A., Kodio A., Doumbia D., et al.: Dynamics of Pfcrt K76T and Pfmdr1N86Y fifteen years after the withdrawal of chloroquine in Mali. AJPME. 2(1), 0–0 (2024) doi: 10.35995/ajpme2010004 DamaS. DiakiteB. DinkormaO.T. NiangalyA. KoneA.K. DaraA. KoneA. BamadioA. KodioA. DoumbiaD. Dynamics of Pfcrt K76T and Pfmdr1N86Y fifteen years after the withdrawal of chloroquine in Mali AJPME 2 1 0 0 2024 10.35995/ajpme2010004 Open DOI

35.Doliwa C., Escotte-Binet S., Aubert D., Sauvage V., Velard F., Schmid A., Villena I.: Sulfadiazine resistance in Toxoplasma gondii: no involvement of overexpression or polymorphisms in genes of therapeutic targets and ABC transporters. Parasite. 20, 19 (2013) doi: 10.1051/parasite/2013020 DoliwaC. Escotte-BinetS. AubertD. SauvageV. VelardF. SchmidA. VillenaI. Sulfadiazine resistance in Toxoplasma gondii: no involvement of overexpression or polymorphisms in genes of therapeutic targets and ABC transporters Parasite 20 19 2013 10.1051/parasite/2013020 Open DOI

36.Dubey J.P.: Toxoplasmosis of Animals and Humans. 3rd ed. Boca Raton: CRC Press. (2021) DubeyJ.P. Toxoplasmosis of Animals and Humans 3rd ed Boca Raton CRC Press 2021 Search in Google Scholar

37.Dubey J.P. and Jones J.L.: Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol. 38(11) 1257–1278 (2008) doi: 10.1016/j.ijpara.2008.03.007 DubeyJ.P. JonesJ.L. Toxoplasma gondii infection in humans and animals in the United States Int J Parasitol. 38 11 1257 1278 2008 10.1016/j.ijpara.2008.03.007 Open DOI

38.Dunay I.R., Gajurel K., Dhakal R., Liesenfeld O., Montoya J.G.: Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice. Clin Microbiol Rev. 31(4), e00057–17 (2018) doi: 10.1128/CMR.00057-17 DunayI.R. GajurelK. DhakalR. LiesenfeldO. MontoyaJ.G. Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice Clin Microbiol Rev. 31 4 e00057–17 2018 10.1128/CMR.00057-17 Open DOI

39.Faucher B., Pomares C., Fourcade S., Benyamine A., Marty P., Pratlong L., Faraut F., Mary C., Piarroux R., Dedet J.P., et al.: Mucosal Leishmania infantum leishmaniasis: specific pattern in a multicentre survey and historical cases. J Infect. 63(1), 76–82 (2011) doi: 10.1016/j.jinf.2011.03.012 FaucherB. PomaresC. FourcadeS. BenyamineA. MartyP. PratlongL. FarautF. MaryC. PiarrouxR. DedetJ.P. Mucosal Leishmania infantum leishmaniasis: specific pattern in a multicentre survey and historical cases J Infect 63 1 76 82 2011 10.1016/j.jinf.2011.03.012 Open DOI

40.Reed D.A., Nomura T., Talley A.K., Cooper R.A., Dzekunov S.M., Ferdig M.T., Ursos L.M., Sidhu A.B., Naudé B., Deitsch K.W., et al.: Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell. 6(4), 861–871 (2000) doi: 10.1016/s1097-2765(05)00077-8 ReedD.A. NomuraT. TalleyA.K. CooperR.A. DzekunovS.M. FerdigM.T. UrsosL.M. SidhuA.B. NaudéB. DeitschK.W. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance Mol Cell 6 4 861 871 2000 10.1016/s1097-2765(05)00077-8 Open DOI

41.Franco J.R., Priotto G., Paone M., Cecchi G., Ebeja A.K., Simarro P.P., Sankara D., Metwally S.B.A., Argaw D.D.: The elimination of human African trypanosomiasis: Monitoring progress towards the 2021–2030 WHO road map targets. PLOS Neglected Tropical Diseases 18(4), e0012111 (2024) doi: 10.1371/journal.pntd.0012111 FrancoJ.R. PriottoG. PaoneM. CecchiG. EbejaA.K. SimarroP.P. SankaraD. MetwallyS.B.A. ArgawD.D. The elimination of human African trypanosomiasis: Monitoring progress towards the 2021–2030 WHO road map targets PLOS Neglected Tropical Diseases 18 4 e0012111 2024 10.1371/journal.pntd.0012111 Open DOI

42.Gelaw Y.M., Dagnew G.W., Alene G.D., Gangneux J.P., Robert-Gangneux F.: Toxoplasma gondii seroprevalence among pregnant women in Africa: A systematic review and meta-analysis. PLOS Neglected Tropical Diseases. 18(5), e0012198 (2024) doi: 10.1371/journal.pntd.0012198 GelawY.M. DagnewG.W. AleneG.D. GangneuxJ.P. Robert-GangneuxF. Toxoplasma gondii seroprevalence among pregnant women in Africa: A systematic review and meta-analysis PLOS Neglected Tropical Diseases. 18 5 e0012198 2024 10.1371/journal.pntd.0012198 Open DOI

43.Ghosal A., Sardar S.K., Haldar T., Maruf M., Saito-Nakano Y., Dutta S., Nozaki T., Ganguly S.: Genotyping and epidemiological distribution of diarrhea-causing isolates of Giardia duodenalis in southeastern part of West Bengal, India. Parasitol Res. 122(11), 2567–2584 (2023) doi: 10.1007/s00436-023-07956-7.44 GhosalA. SardarS.K. HaldarT. MarufM. Saito-NakanoY. DuttaS. NozakiT. GangulyS. Genotyping and epidemiological distribution of diarrhea-causing isolates of Giardia duodenalis in southeastern part of West Bengal, India Parasitol Res 122 11 2567 2584 2023 10.1007/s00436-023-07956-7.44 Open DOI

44.Gibb H., Devleesschauwer B., Bolger P.M., Wu F., Ezendam J., Cliff J., Zeilmaker M., Verger P., Pitt J., Baines J., et al. World Health Organization estimates of the global and regional disease burden of four foodborne chemical toxins, 2010: a data synthesis. F1000Res. 4, 1393 (2015) doi: 10.12688/f1000research.7340.1 GibbH. DevleesschauwerB. BolgerP.M. WuF. EzendamJ. CliffJ. ZeilmakerM. VergerP. PittJ. BainesJ. World Health Organization estimates of the global and regional disease burden of four foodborne chemical toxins, 2010: a data synthesis F1000Res 4 1393 2015 10.12688/f1000research.7340.1 Open DOI

45.Gil J.P. and Fançony C.: Plasmodium falciparum Multidrug Resistance Proteins (pfMRPs). Front Pharmacol. 12 (2021) doi: 10.3389/fphar.2021.759422 [accessed 2024 Aug 31] https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.759422/full GilJ.P. FançonyC. Plasmodium falciparum Multidrug Resistance Proteins (pfMRPs) Front Pharmacol 12 2021 10.3389/fphar.2021.759422 [accessed 2024 Aug 31] https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.759422/full Open DOI

46.Keating G.M.: Fosfomycin trometamol: A review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria. Drugs. 73, 1951–1966 (2013) https://doi.org/10.1007/s40265-013-0143-y KeatingG.M. Fosfomycin trometamol: A review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria Drugs 73 1951 1966 2013 https://doi.org/10.1007/s40265-013-0143-y Search in Google Scholar

47.Graf F.E., Ludin P., Wenzler T., Kaiser M., Brun R., Pyana P.P., Büscher P., Koning H.P. de, Horn D., Mäser P.: Aquaporin 2 Mutations in Trypanosoma brucei gambiense Field Isolates Correlate with Decreased Susceptibility to Pentamidine and Melarsoprol. PLOS Neglected Tropical Diseases. 7(10), e2475 (2013) doi: 10.1371/journal.pntd.0002475 GrafF.E. LudinP. WenzlerT. KaiserM. BrunR. PyanaP.P. BüscherP. KoningH.P. de HornD. MäserP. Aquaporin 2 Mutations in Trypanosoma brucei gambiense Field Isolates Correlate with Decreased Susceptibility to Pentamidine and Melarsoprol PLOS Neglected Tropical Diseases. 7 10 e2475 2013 10.1371/journal.pntd.0002475 Open DOI

48.Guimaraes J.L., Lourie E.M.: The inhibition of some pharmacological actions of pentamidine by suramin. British Journal of Pharmacology and Chemotherapy. 6(3), 514 (1951) doi: 10.1111/j.1476-5381.1951.tb00663.x GuimaraesJ.L. LourieE.M. The inhibition of some pharmacological actions of pentamidine by suramin British Journal of Pharmacology and Chemotherapy 6 3 514 1951 10.1111/j.1476-5381.1951.tb00663.x Open DOI

49.Gupta P., Singh K., Balodhi A., Jain K., Deeba F., Salam N.: Prevalence of Amoebiasis and Associated Complications in India: A Systematic Review. Acta Parasitologica. 67 (2022) doi: 10.1007/s11686-022-00547-z. GuptaP. SinghK. BalodhiA. JainK. DeebaF. SalamN. Prevalence of Amoebiasis and Associated Complications in India: A Systematic Review Acta Parasitologica 67 2022 10.1007/s11686-022-00547-z Open DOI

50.Hajj R.E., Tawk L., Itani S., Hamie M., Ezzeddine J., El Sabban M., El Hajj H.: Toxoplasmosis: Current and Emerging Parasite Druggable Targets. Microorganisms. 9(12), 2531 (2021) doi: 10.3390/microorganisms9122531 HajjR.E. TawkL. ItaniS. HamieM. EzzeddineJ. El SabbanM. El HajjH. Toxoplasmosis: Current and Emerging Parasite Druggable Targets Microorganisms 9 12 2531 2021 10.3390/microorganisms9122531 Open DOI

51.Hammershaimb E.A. and Berry A.A.: Pre-erythrocytic malaria vaccines: RTS,S, R21, and beyond. Expert Review of Vaccines. 23(1), 49–52 (2024) doi: 10.1080/14760584.2023.2292204 HammershaimbE.A. BerryA.A. Pre-erythrocytic malaria vaccines: RTS,S, R21, and beyond Expert Review of Vaccines 23 1 49 52 2024 10.1080/14760584.2023.2292204 Open DOI

52.Hassen J., Alemayehu G.S., Dinka H., Golassa L.: High prevalence of Pfcrt 76T and Pfmdr1 N86 genotypes in malaria infected patients attending health facilities in East Shewa zone, Oromia Regional State, Ethiopia. Malaria Journal. 21(1), 286 (2022) doi: 10.1186/s12936-022-04304-5 HassenJ. AlemayehuG.S. DinkaH. GolassaL. High prevalence of Pfcrt 76T and Pfmdr1 N86 genotypes in malaria infected patients attending health facilities in East Shewa zone, Oromia Regional State, Ethiopia Malaria Journal 21 1 286 2022 10.1186/s12936-022-04304-5 Open DOI

53.Herwaldt B.L., Berman J.D.: Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg. 46(3), 296–306 (1992) doi: 10.4269/ajtmh.1992.46.296 HerwaldtB.L. BermanJ.D. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies Am J Trop Med Hyg 46 3 296 306 1992 10.4269/ajtmh.1992.46.296 Open DOI

54.Hung D.T., Tran L., Tam D.N.H., Elshafei G., Cuong N.T.K., Ha N.X., Khader S.A.E., Le Quang L., Shaikhkhalil H.W., Abdallfatah A., et al.: The prevalence of Pfk13 polymorphism in malaria patients treated with artemisinin-based therapy: a systematic review and meta-analysis. Parasitol Res. 123(5), 209 (2024) doi: 10.1007/s00436-024-08203-3 HungD.T. TranL. TamD.N.H. ElshafeiG. CuongN.T.K. HaN.X. KhaderS.A.E. Le QuangL. ShaikhkhalilH.W. AbdallfatahA. The prevalence of Pfk13 polymorphism in malaria patients treated with artemisinin-based therapy: a systematic review and meta-analysis Parasitol Res 123 5 209 2024 10.1007/s00436-024-08203-3 Open DOI

55.Imwong M., Pukrittakayamee S., Looareesuwan S., Pasvol G., Poirreiz J., White N.J., Snounou G.: Association of Genetic Mutations in Plasmodium vivax dhfr with Resistance to Sulfadoxine-Pyrimethamine: Geographical and Clinical Correlates. Anti­ microbial Agents and Chemotherapy. 45(11), 3122–3127 (2001) doi: 10.1128/aac.45.11.3122-3127.2001 ImwongM. PukrittakayameeS. LooareesuwanS. PasvolG. PoirreizJ. WhiteN.J. SnounouG. Association of Genetic Mutations in Plasmodium vivax dhfr with Resistance to Sulfadoxine-Pyrimethamine: Geographical and Clinical Correlates Anti­ microbial Agents and Chemotherapy 45 11 3122 3127 2001 10.1128/aac.45.11.3122-3127.2001 Open DOI

56.Issa I., Lamine M.M., Hubert V., Ilagouma A., Adehossi E., Mahamadou A., Lobo N.F., Sarr D., Shollenberger L.M., Sandrine H., et al. Prevalence of Mutations in the Pfdhfr, Pfdhps, and Pfmdr1 Genes of Malarial Parasites Isolated from Symptomatic Patients in Dogondoutchi, Niger. Tropical Medicine and Infectious Disease. 7(8), 155 (2022) doi: 10.3390/tropicalmed7080155 IssaI. LamineM.M. HubertV. IlagoumaA. AdehossiE. MahamadouA. LoboN.F. SarrD. ShollenbergerL.M. SandrineH. Prevalence of Mutations in the Pfdhfr, Pfdhps, and Pfmdr1 Genes of Malarial Parasites Isolated from Symptomatic Patients in Dogondoutchi, Niger Tropical Medicine and Infectious Disease 7 8 155 2022 10.3390/tropicalmed7080155 Open DOI

57.Jackson D., Salem A., Coombs G.H.: The in­vitro activity of metronidazole against strains of Escherichia coli with impaired DNA repair systems. Journal of Antimicrobial Chemotherapy. 13(3), 227–236 (1984) doi: 10.1093/jac/13.3.227 JacksonD. SalemA. CoombsG.H. The in­vitro activity of metronidazole against strains of Escherichia coli with impaired DNA repair systems Journal of Antimicrobial Chemotherapy 13 3 227 236 1984 10.1093/jac/13.3.227 Open DOI

58.Johnson A.M.: Toxoplasma: Biology, Pathology, Immunology, and Treatment. In: Coccidiosis of Man and Domestic Animals. CRC Press. 34 p. (1990) JohnsonA.M. Toxoplasma: Biology, Pathology, Immunology, and Treatment In: Coccidiosis of Man and Domestic Animals CRC Press 34 1990 Search in Google Scholar

59.Jones J.L., Kruszon-Moran D., Elder S., Rivera H.N., Press C., Montoya J.G., McQuillan G.M.: Toxoplasma gondii Infection in the United States. Am J Trop Med Hyg. 98(2), 551–557 (2018) doi: 10.4269/ajtmh.17-0677 JonesJ.L. Kruszon-MoranD. ElderS. RiveraH.N. PressC. MontoyaJ.G. McQuillanG.M. Toxoplasma gondii Infection in the United States Am J Trop Med Hyg 98 2 551 557 2018 10.4269/ajtmh.17-0677 Open DOI

60.Kalavani S, Matin S., Rahmanian V., Meshkin A., Bahadori Mazidi B., Taghipour A., Abdoli A.: Prevalence of Giardia duodenalis among African children: A systematic review and meta-analysis. Parasite Epidemiology and Control. 26, e00365 (2024) doi: 10.1016/j.parepi.2024.e00365 KalavaniS MatinS. RahmanianV. MeshkinA. Bahadori MazidiB. TaghipourA. AbdoliA. Prevalence of Giardia duodenalis among African children: A systematic review and meta-analysis Parasite Epidemiology and Control 26 e00365 2024 10.1016/j.parepi.2024.e00365 Open DOI

61.Kaplan B., Kahn L.H., Monath T.P., Woodall J.: “ONE HEALTH” and parasitology. Parasites & Vectors. 2(1), 36 (2009) doi: 10.1186/1756-3305-2-36 KaplanB. KahnL.H. MonathT.P. WoodallJ. “ONE HEALTH” and parasitology Parasites & Vectors 2 1 36 2009 10.1186/1756-3305-2-36 Open DOI

62.Koné M., Kaba D., Kaboré J., Thomas L.F., Falzon L.C., Koffi M., Kouamé C.M., Ahouty B., Compaoré C.F.A., N’Gouan E.K., et al.: Passive surveillance of human African trypanosomiasis in Côte d’Ivoire: Understanding prevalence, clinical symptoms and signs, and diagnostic test characteristics. PLOS Neglected Tropical Diseases. 15(8) e0009656 (2021) doi: 10.1371/journal.pntd.0009656 KonéM. KabaD. KaboréJ. ThomasL.F. FalzonL.C. KoffiM. KouaméC.M. AhoutyB. CompaoréC.F.A. N’GouanE.K. Passive surveillance of human African trypanosomiasis in Côte d’Ivoire: Understanding prevalence, clinical symptoms and signs, and diagnostic test characteristics PLOS Neglected Tropical Diseases 15 8 e0009656 2021 10.1371/journal.pntd.0009656 Open DOI

63.de Koning H.P., Anderson L.F., Stewart M., Burchmore R.J.S., Wallace L.J.M., Barrett M.P.: The Trypanocide Diminazene Aceturate Is Accumulated Predominantly through the TbAT1 Purine Transporter: Additional Insights on Diamidine Resistance in African Trypanosomes. Antimicrobial Agents and Chemo­therapy. 48(5), 1515–1519 (2004) doi: 10.1128/aac.48.5.1515-1519.2004 de KoningH.P. AndersonL.F. StewartM. BurchmoreR.J.S. WallaceL.J.M. BarrettM.P. The Trypanocide Diminazene Aceturate Is Accumulated Predominantly through the TbAT1 Purine Transporter: Additional Insights on Diamidine Resistance in African Trypanosomes Antimicrobial Agents and Chemo­therapy 48 5 1515 1519 2004 10.1128/aac.48.5.1515-1519.2004 Open DOI

64.Konstantinovic N, Guegan H, Stäjner T, Belaz S, Robert-Gangneux F. 2019. Treatment of toxoplasmosis: Current options and future perspectives. Food and Waterborne Parasitology. 15:e00036. doi:10.1016/j.fawpar.2019.e00036. KonstantinovicN GueganH StäjnerT BelazS Robert-GangneuxF 2019 Treatment of toxoplasmosis: Current options and future perspectives Food and Waterborne Parasitology 15 e00036 10.1016/j.fawpar.2019.e00036 Open DOISearch in Google Scholar

65.Krakovka S., Ribacke U., Miyamoto Y., Eckmann L., Svärd S.: Characterization of Metronidazole-Resistant Giardia intestinalis Lines by Comparative Transcriptomics and Proteomics. Front Microbiol. 13 (2022) doi: 10.3389/fmicb.2022.834008 [accessed 2024 Aug 27] https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2022.834008/full KrakovkaS. RibackeU. MiyamotoY. EckmannL. SvärdS. Characterization of Metronidazole-Resistant Giardia intestinalis Lines by Comparative Transcriptomics and Proteomics Front Microbiol 13 2022 10.3389/fmicb.2022.834008 [accessed 2024 Aug 27] https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2022.834008/full Open DOI

66.Lagunas-Rangel F.A., Yee J., Bermúdez-Cruz R.M.: An update on cell division of Giardia duodenalis trophozoites. Microbiological Research. 250, 126807 (2021) doi: 10.1016/j.micres.2021.126807 Lagunas-RangelF.A. YeeJ. Bermúdez-CruzR.M. An update on cell division of Giardia duodenalis trophozoites Microbiological Research 250 126807 2021 10.1016/j.micres.2021.126807 Open DOI

67.Lapinskas P.J. and Ben-Harari R.R.: Perspective on current and emerging drugs in the treatment of acute and chronic toxoplasmosis. Postgraduate Medicine. 131(8), 589–596 (2019) doi: 10.1080/00325481.2019.1655258 LapinskasP.J. Ben-HarariR.R. Perspective on current and emerging drugs in the treatment of acute and chronic toxoplasmosis Postgraduate Medicine 131 8 589 596 2019 10.1080/00325481.2019.1655258 Open DOI

68.Makarov A., Began J., Mautone I.C., Pinto E., Ferguson L., Zoltner M., Zoll S., Field M.C.: The role of invariant surface glycoprotein 75 in xenobiotic acquisition by African trypanosomes. Microb Cell. 10(2), 18–35 (2023) doi: 10.15698/mic2023.02.790 MakarovA. BeganJ. MautoneI.C. PintoE. FergusonL. ZoltnerM. ZollS. FieldM.C. The role of invariant surface glycoprotein 75 in xenobiotic acquisition by African trypanosomes Microb Cell 10 2 18 35 2023 10.15698/mic2023.02.790 Open DOI

69.Mann S., Frasca K., Scherrer S., Henao-Martínez A.F., Newman S., Ramanan P., Suarez J.A.: A Review of Leishmaniasis: Current Knowledge and Future Directions. Curr Trop Med Rep. 8(2), 121–132 (2021) doi: 10.1007/s40475-021-00232-7 MannS. FrascaK. ScherrerS. Henao-MartínezA.F. NewmanS. RamananP. SuarezJ.A. A Review of Leishmaniasis: Current Knowledge and Future Directions Curr Trop Med Rep 8 2 121 132 2021 10.1007/s40475-021-00232-7 Open DOI

70.Marques M.M., Costa M.R.F., Santana Filho F.S., Vieira J.L.F., Nascimento M.T.S., Brasil L.W., Nogueira F., Silveira H., Reyes-Lecca R.C., Monteiro W.M., et al.: Plasmodium vivax Chloroquine Resistance and Anemia in the Western Brazilian Amazon. Antimicrobial Agents and Chemotherapy. 58(1), 342–347 (2014) doi: 10.1128/aac.02279-12 MarquesM.M. CostaM.R.F. Santana FilhoF.S. VieiraJ.L.F. NascimentoM.T.S. BrasilL.W. NogueiraF. SilveiraH. Reyes-LeccaR.C. MonteiroW.M. Plasmodium vivax Chloroquine Resistance and Anemia in the Western Brazilian Amazon Antimicrobial Agents and Chemotherapy 58 1 342 347 2014 10.1128/aac.02279-12 Open DOI

71.Matovu E., Stewart M.L., Geiser F., Brun R., Mäser P., Wallace L.J.M., Burchmore R.J., Enyaru J.C.K., Barrett M.P., Kaminsky R., et al.: Mechanisms of Arsenical and Diamidine Uptake and Resistance in Trypanosoma brucei. Eukaryotic Cell. 2(5), 1003–1008 (2003) doi: 10.1128/ec.2.5.1003-1008.2003 MatovuE. StewartM.L. GeiserF. BrunR. MäserP. WallaceL.J.M. BurchmoreR.J. EnyaruJ.C.K. BarrettM.P. KaminskyR. Mechanisms of Arsenical and Diamidine Uptake and Resistance in Trypanosoma brucei Eukaryotic Cell 2 5 1003 1008 2003 10.1128/ec.2.5.1003-1008.2003 Open DOI

72.McFadden D.C., Tomavo S., Berry E.A., Boothroyd J.C.: Characterization of cytochrome b from Toxoplasma gondii and Qo domain mutations as a mechanism of atovaquone-resistance. Molecular and Biochemical Parasitology. 108(1), 1–12 (2000) doi: 10.1016/S0166-6851(00)00184-5 McFaddenD.C. TomavoS. BerryE.A. BoothroydJ.C. Characterization of cytochrome b from Toxoplasma gondii and Qo domain mutations as a mechanism of atovaquone-resistance Molecular and Biochemical Parasitology 108 1 1 12 2000 10.1016/S0166-6851(00)00184-5 Open DOI

73.Meneceur P., Bouldouyre M.A., Aubert D., Villena I., Menotti J., Sauvage V., Garin J.F., Derouin F.: In Vitro Susceptibility of Various Genotypic Strains of Toxoplasma gondii to Pyrimethamine, Sulfadiazine, and Atovaquone. Antimicrob Agents Chemother. 52(4), 1269–1277 (2008) doi: 10.1128/AAC.01203-07 MeneceurP. BouldouyreM.A. AubertD. VillenaI. MenottiJ. SauvageV. GarinJ.F. DerouinF. In Vitro Susceptibility of Various Genotypic Strains of Toxoplasma gondii to Pyrimethamine, Sulfadiazine, and Atovaquone Antimicrob Agents Chemother 52 4 1269 1277 2008 10.1128/AAC.01203-07 Open DOI

74.Meshnick S.R. and Dobson M.J.: The History of Antimalarial Drugs. In: Rosenthal PJ, editor. Antimalarial Chemotherapy: Mechanisms of Action, Resistance, and New Directions in Drug Discovery. Totowa, NJ: Humana Press. p. 15–25 (2001) [accessed 2024 Sep 7] https://doi.org/10.1007/978-1-59259-111-4_2 MeshnickS.R. DobsonM.J. The History of Antimalarial Drugs In: RosenthalPJ editor Antimalarial Chemotherapy: Mechanisms of Action, Resistance, and New Directions in Drug Discovery Totowa, NJ Humana Press 15 25 2001 [accessed 2024 Sep 7] https://doi.org/10.1007/978-1-59259-111-4_2 Search in Google Scholar

75.Minbaeva G., Schweiger A., Bodosheva A., Kuttubaev O., Hehl A.B., Tanner I., Ziadinov I., Torgerson P.R., Deplazes P.: Toxoplasma gondii infection in Kyrgyzstan: seroprevalence, risk factor analysis, and estimate of congenital and AIDS-related toxoplasmosis. PLoS Negl Trop Dis. 7(2), e2043 (2013) doi: 10.1371/journal.pntd.0002043 MinbaevaG. SchweigerA. BodoshevaA. KuttubaevO. HehlA.B. TannerI. ZiadinovI. TorgersonP.R. DeplazesP. Toxoplasma gondii infection in Kyrgyzstan: seroprevalence, risk factor analysis, and estimate of congenital and AIDS-related toxoplasmosis PLoS Negl Trop Dis. 7 2 e2043 2013 10.1371/journal.pntd.0002043 Open DOI

76.Monis P.T., Caccio S.M., Thompson R.C.A.: Variation in Giardia: towards a taxonomic revision of the genus. Trends in Parasitology. 25(2), 93–100 (2009) doi: 10.1016/j.pt.2008.11.006 MonisP.T. CaccioS.M. ThompsonR.C.A. Variation in Giardia: towards a taxonomic revision of the genus Trends in Parasitology 25 2 93 100 2009 10.1016/j.pt.2008.11.006 Open DOI

77.Moreira E.T. de S., Castro Faria Neto H.C. de, Reis P.A.: Chapter 17 – Cerebral malaria: Understanding the parasite pathogenesis in the brain. In: De Quevedo JL, Barichello T, Hasbun R, Dal-Pizzol F, editors. Neurobiology of Infectious Diseases. Academic Press. (Neurobiology of Disease). p. 291–304 (2025) MoreiraE.T. de S. Castro Faria NetoH.C. de ReisP.A. Chapter 17 – Cerebral malaria: Understanding the parasite pathogenesis in the brain In: De QuevedoJL BarichelloT HasbunR Dal-PizzolF editors Neurobiology of Infectious Diseases Academic Press (Neurobiology of Disease) 291 304 2025 Search in Google Scholar

78.Moss S., Mańko E., Krishna S., Campino S., Clark T.G., Last A.: How has mass drug administration with dihydroartemisininpiperaquine impacted molecular markers of drug resistance? A systematic review. Malar J. 21(1), 186 (2022) doi: 10.1186/s12936-022-04181-y MossS. MańkoE. KrishnaS. CampinoS. ClarkT.G. LastA. How has mass drug administration with dihydroartemisininpiperaquine impacted molecular markers of drug resistance? A systematic review Malar J 21 1 186 2022 10.1186/s12936-022-04181-y Open DOI

79.Mukherjee A., Padmanabhan P.K., Singh S., Roy G., Girard I., Chatterjee M., Ouellette M., Madhubala R.: Role of ABC transporter MRPA, γ-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani. Journal of Antimicrobial Chemotherapy. 59(2), 204–211 (2007) doi: 10.1093/jac/dkl494 MukherjeeA. PadmanabhanP.K. SinghS. RoyG. GirardI. ChatterjeeM. OuelletteM. MadhubalaR. Role of ABC transporter MRPA, γ-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani Journal of Antimicrobial Chemotherapy 59 2 204 211 2007 10.1093/jac/dkl494 Open DOI

80.Munday J.C., Eze A.A., Baker N., Glover L., Clucas C., Aguinaga Andrés D., Natto M.J., Teka I.A., McDonald J., Lee R.S., et al. Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs. Journal of Antimicrobial Chemotherapy. 69(3), 651–663 (2014) doi: 10.1093/jac/dkt442 MundayJ.C. EzeA.A. BakerN. GloverL. ClucasC. Aguinaga AndrésD. NattoM.J. TekaI.A. McDonaldJ. LeeR.S. Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs Journal of Antimicrobial Chemotherapy 69 3 651 663 2014 10.1093/jac/dkt442 Open DOI

81.Munday J.C., Settimo L., de Koning H.P.: Transport proteins determine drug sensitivity and resistance in a protozoan parasite, Trypanosoma brucei. Front Pharmacol. 6 (2015) doi: 10.3389/fphar.2015.00032 MundayJ.C. SettimoL. de KoningH.P. Transport proteins determine drug sensitivity and resistance in a protozoan parasite, Trypanosoma brucei Front Pharmacol 6 2015 10.3389/fphar.2015.00032 Open DOI

82.Naghavi M., Mestrovic T., Gray A., Hayoon A.G., Swetschinski L.R., Aguilar G.R., Weaver N.D., Ikuta K.S., Chung E., Wool E.E., et al.: Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Infectious Diseases. 24(8), 868–895 (2024) doi: 10.1016/S1473-3099(24)00158-0 NaghaviM. MestrovicT. GrayA. HayoonA.G. SwetschinskiL.R. AguilarG.R. WeaverN.D. IkutaK.S. ChungE. WoolE.E. Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 The Lancet Infectious Diseases 24 8 868 895 2024 10.1016/S1473-3099(24)00158-0 Open DOI

83.Nok A.J.: Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis. Parasitol Res. 90(1), 71–79 (2003) doi: 10.1007/s00436-002-0799-9 NokA.J. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis Parasitol Res 90 1 71 79 2003 10.1007/s00436-002-0799-9 Open DOI

84.Noronha M., Pawar V., Prajapati A., Subramanian R.B.: A literature review on traditional herbal medicines for malaria. South African Journal of Botany. 128 292–303 (2020) doi: 10.1016/j.sajb.2019.11.017 NoronhaM. PawarV. PrajapatiA. SubramanianR.B. A literature review on traditional herbal medicines for malaria South African Journal of Botany 128 292 303 2020 10.1016/j.sajb.2019.11.017 Open DOI

85.Nsobya S.L., Dokomajilar C., Joloba M., Dorsey G., Rosenthal P.J.: Resistance-Mediating Plasmodium falciparum pfcrt and pfmdr1 Alleles after Treatment with Artesunate-Amodiaquine in Uganda. Antimicrobial Agents and Chemotherapy. 51(8), 3023–3025 (2007) doi: 10.1128/aac.00012-07 NsobyaS.L. DokomajilarC. JolobaM. DorseyG. RosenthalP.J. Resistance-Mediating Plasmodium falciparum pfcrt and pfmdr1 Alleles after Treatment with Artesunate-Amodiaquine in Uganda Antimicrobial Agents and Chemotherapy 51 8 3023 3025 2007 10.1128/aac.00012-07 Open DOI

86.O’Neill P.M., Barton V.E., Ward S.A.: The molecular mechanism of action of artemisinin-the debate continues. Molecules. 15(3), 1705–1721 (2010) doi: 10.3390/molecules15031705 O’NeillP.M. BartonV.E. WardS.A. The molecular mechanism of action of artemisinin-the debate continues Molecules 15 3 1705 1721 2010 10.3390/molecules15031705 Open DOI

87.Pacheco M.A., Schneider K.A., Cheng Q., Munde E.O., Ndege C., Onyango C., Raballah E., Anyona S.B., Ouma C., Perkins D.J., et al. Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H. Malar J. 19(1), 378 (2020) doi: 10.1186/s12936-020-03454-8 PachecoM.A. SchneiderK.A. ChengQ. MundeE.O. NdegeC. OnyangoC. RaballahE. AnyonaS.B. OumaC. PerkinsD.J. Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H Malar J 19 1 378 2020 10.1186/s12936-020-03454-8 Open DOI

88.Patel P., Bharti P.K., Bansal D., Ali N.A., Raman R.K., Mohapatra P.K., Sehgal R., Mahanta J., Sultan A.A., Singh N.: Prevalence of mutations linked to antimalarial resistance in Plasmodium falciparum from Chhattisgarh, Central India: A malaria elimination point of view. Sci Rep. 7(1), 16690 (2017) doi: 10.1038/s41598-017-16866-5 PatelP. BhartiP.K. BansalD. AliN.A. RamanR.K. MohapatraP.K. SehgalR. MahantaJ. SultanA.A. SinghN. Prevalence of mutations linked to antimalarial resistance in Plasmodium falciparum from Chhattisgarh, Central India: A malaria elimination point of view Sci Rep 7 1 16690 2017 10.1038/s41598-017-16866-5 Open DOI

89.Pérez-Victoria J.M., Bavchvarov B.I., Torrecillas I.R., Martínez-García M., López-Martín C., Campillo M., Castanys S., Gamarro F.: Sitamaquine overcomes ABC-mediated resistance to miltefosine and antimony in Leishmania. Antimicrob Agents Chemother. 55(8), 3838–3844 (2011) doi: 10.1128/AAC.00065-11 Pérez-VictoriaJ.M. BavchvarovB.I. TorrecillasI.R. Martínez-GarcíaM. López-MartínC. CampilloM. CastanysS. GamarroF. Sitamaquine overcomes ABC-mediated resistance to miltefosine and antimony in Leishmania Antimicrob Agents Chemother 55 8 3838 3844 2011 10.1128/AAC.00065-11 Open DOI

90.Perry D., Dixon K., Garlapati R., Gendernalik A., Poché D., Poché R.: Visceral Leishmaniasis Prevalence and Associated Risk Factors in the Saran District of Bihar, India, from 2009 to July of 2011. Am J Trop Med Hyg. 88(4), 778–784 (2013) doi: 10.4269/ajtmh.12-0442 PerryD. DixonK. GarlapatiR. GendernalikA. PochéD. PochéR. Visceral Leishmaniasis Prevalence and Associated Risk Factors in the Saran District of Bihar, India, from 2009 to July of 2011 Am J Trop Med Hyg 88 4 778 784 2013 10.4269/ajtmh.12-0442 Open DOI

91.Pinart M., Rueda J.R., Romero G.A., Pinzón-Flórez C.E., Osorio-Arango K., Silveira Maia-Elkhoury A.N., Reveiz L., Elias V.M., Tweed J.A.: Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane Database Syst Rev. 2020(8), CD004834 92020) doi: 10.1002/14651858.CD004834.pub3 PinartM. RuedaJ.R. RomeroG.A. Pinzón-FlórezC.E. Osorio-ArangoK. Silveira Maia-ElkhouryA.N. ReveizL. EliasV.M. TweedJ.A. Interventions for American cutaneous and mucocutaneous leishmaniasis Cochrane Database Syst Rev 2020 8 CD004834 92020 10.1002/14651858.CD004834.pub3 Open DOI

92.Pluijm R.W. van der, Amaratunga C., Dhorda M., Dondorp A.M.: Triple Artemisinin-Based Combination Therapies for Malaria – A New Paradigm? Trends in Parasitology 37(1), 15–24 (2021) doi: 10.1016/j.pt.2020.09.011 PluijmR.W. van der AmaratungaC. DhordaM. DondorpA.M. Triple Artemisinin-Based Combination Therapies for Malaria – A New Paradigm? Trends in Parasitology 37 1 15 24 2021 10.1016/j.pt.2020.09.011 Open DOI

93.Ponte-Sucre A., Gamarro F., Dujardin J.C., Barrett M.P., López-Vélez R., García-Hernández R., Pountain A.W., Mwenechanya R., Papadopoulou B.: Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. PLOS Neglected Tropical Diseases 11(12), e0006052 (2017) doi: 10.1371/journal.pntd.0006052 Ponte-SucreA. GamarroF. DujardinJ.C. BarrettM.P. López-VélezR. García-HernándezR. PountainA.W. MwenechanyaR. PapadopoulouB. Drug resistance and treatment failure in leishmaniasis: A 21st century challenge PLOS Neglected Tropical Diseases 11 12 e0006052 2017 10.1371/journal.pntd.0006052 Open DOI

94.Potvin J.E., Leprohon P., Queffeulou M., Sundar S., Ouellette M.: Mutations in an Aquaglyceroporin as a Proven Marker of Antimony Clinical Resistance in the Parasite Leishmania donovani. Clin Infect Dis. 72(10), e526–e532 (2020) doi: 10.1093/cid/ciaa1236 PotvinJ.E. LeprohonP. QueffeulouM. SundarS. OuelletteM. Mutations in an Aquaglyceroporin as a Proven Marker of Antimony Clinical Resistance in the Parasite Leishmania donovani Clin Infect Dis. 72 10 e526 e532 2020 10.1093/cid/ciaa1236 Open DOI

95.Pountain A.W., Weidt S.K., Regnault C., Bates P.A., Donachie A.M., Dickens N.J., Barrett M.P.: Genomic instability at the locus of sterol C24-methyltransferase promotes amphotericin B resistance in Leishmania parasites. PLoS Negl Trop Dis. 13(2), e0007052 (2019) doi: 10.1371/journal.pntd.0007052 PountainA.W. WeidtS.K. RegnaultC. BatesP.A. DonachieA.M. DickensN.J. BarrettM.P. Genomic instability at the locus of sterol C24-methyltransferase promotes amphotericin B resistance in Leishmania parasites PLoS Negl Trop Dis. 13 2 e0007052 2019 10.1371/journal.pntd.0007052 Open DOI

96.Prusa A.R., Kasper D.C., Pollak A., Olischar M., Gleiss A., Hayde M.: Amniocentesis for the detection of congenital toxoplasmosis: results from the nationwide Austrian prenatal screening program. Clinical Microbiology and Infection. 21(2), 191.e1–191.e8 (2015) doi: 10.1016/j.cmi.2014.09.018 PrusaA.R. KasperD.C. PollakA. OlischarM. GleissA. HaydeM. Amniocentesis for the detection of congenital toxoplasmosis: results from the nationwide Austrian prenatal screening program Clinical Microbiology and Infection. 21 2 191.e1 191.e8 2015 10.1016/j.cmi.2014.09.018 Open DOI

97.Pulcini S., Staines H.M., Lee A.H., Shafik S.H., Bouyer G., Moore C.M., Daley D.A., Hoke M.J., Altenhofen L.M., Painter H.J., et al.: Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite’s food vacuole and alter drug sensitivities. Sci Rep. 5(1), 14552 (2015) doi: 10.1038/srep14552 PulciniS. StainesH.M. LeeA.H. ShafikS.H. BouyerG. MooreC.M. DaleyD.A. HokeM.J. AltenhofenL.M. PainterH.J. Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite’s food vacuole and alter drug sensitivities Sci Rep 5 1 14552 2015 10.1038/srep14552 Open DOI

98.Reed M.B., Saliba K.J., Caruana S.R., Kirk K., Cowman A.F.: Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature. 403(6772), 906–909 (2000) doi: 10.1038/35002615 ReedM.B. SalibaK.J. CaruanaS.R. KirkK. CowmanA.F. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum Nature 403 6772 906 909 2000 10.1038/35002615 Open DOI

99.Rénia L. and Goh Y.S.: Malaria Parasites: The Great Escape. Front Immunol. 7 (2016) doi: 10.3389/fimmu.2016.00463 RéniaL. GohY.S. Malaria Parasites: The Great Escape Front Immunol 7 2016 10.3389/fimmu.2016.00463 Open DOI

100.Riches A., Hart C.J.S., Trenholme K.R., Skinner-Adams T.S.: Anti-Giardia Drug Discovery: Current Status and Gut Feelings. J Med Chem. 63(22), 13330–13354 (2020) doi: 10.1021/acs.jmedchem.0c00910 RichesA. HartC.J.S. TrenholmeK.R. Skinner-AdamsT.S. Anti-Giardia Drug Discovery: Current Status and Gut Feelings J Med Chem 63 22 13330 13354 2020 10.1021/acs.jmedchem.0c00910 Open DOI

101.Robert-Gangneux F., Murat J.B., Fricker-Hidalgo H., Brenier-Pinchart M.P., Gangneux J.P., Pelloux H.: The placenta: a main role in congenital toxoplasmosis? Trends Parasitol. 27(12), 530–536 (2011) doi: 10.1016/j.pt.2011.09.005 Robert-GangneuxF. MuratJ.B. Fricker-HidalgoH. Brenier-PinchartM.P. GangneuxJ.P. PellouxH. The placenta: a main role in congenital toxoplasmosis? Trends Parasitol 27 12 530 536 2011 10.1016/j.pt.2011.09.005 Open DOI

102.Rodrigo C., Rajapakse S., Fernando D.: Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. Cochrane Database Syst Rev. 2020(9), CD010458 (2020) doi: 10.1002/14651858.CD010458.pub3 RodrigoC. RajapakseS. FernandoD. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria Cochrane Database Syst Rev 2020 9 CD010458 2020 10.1002/14651858.CD010458.pub3 Open DOI

103.Roro G.B., Eriso F., Al-Hazimi A.M., Kuddus M., Singh S.C., Upadhye V., Hajare S.T.: Prevalence and associated risk factors of Entamoeba histolytica infection among school children from three primary schools in Arsi Town, West Zone, Ethiopia. J Parasit Dis. 46(3), 776–784 (2022) doi: 10.1007/s12639-022-01495-1 RoroG.B. ErisoF. Al-HazimiA.M. KuddusM. SinghS.C. UpadhyeV. HajareS.T. Prevalence and associated risk factors of Entamoeba histolytica infection among school children from three primary schools in Arsi Town, West Zone, Ethiopia J Parasit Dis 46 3 776 784 2022 10.1007/s12639-022-01495-1 Open DOI

104.SA Maternal & Neonatal Clinical Network. South Australian Perinatal Practice Guidelines toxoplasmosis in pregnancy. (2015) SA Maternal & Neonatal Clinical Network South Australian Perinatal Practice Guidelines toxoplasmosis in pregnancy 2015 Search in Google Scholar

105.Sands M., Kron M.A., Brown R.B.: Pentamidine: A Review. Reviews of Infectious Diseases. 7(5), 625–6344 (1985) doi: 10.1093/clinids/7.5.625 SandsM. KronM.A. BrownR.B. Pentamidine: A Review Reviews of Infectious Diseases 7 5 625 6344 1985 10.1093/clinids/7.5.625 Open DOI

106.Sasidharan S. and Saudagar P.: Leishmaniasis: where are we and where are we heading? Parasitol Res. 120(5), 1541–1554 (2021) doi: 10.1007/s00436-021-07139-2 SasidharanS. SaudagarP. Leishmaniasis: where are we and where are we heading? Parasitol Res 120 5 1541 1554 2021 10.1007/s00436-021-07139-2 Open DOI

107.Sawyer P.R., Brogden R.N., Pinder R.M., Speight T.M., Avery G.S.: Tinidazole: a review of its antiprotozoal activity and therapeutic efficacy. Drugs. 11(6), 423–440 (1976) doi: 10.2165/00003495-197611060-00003 SawyerP.R. BrogdenR.N. PinderR.M. SpeightT.M. AveryG.S. Tinidazole: a review of its antiprotozoal activity and therapeutic efficacy Drugs 11 6 423 440 1976 10.2165/00003495-197611060-00003 Open DOI

108.Schousboe M.L., Ranjitkar S., Rajakaruna R.S., Amerasinghe P.H., Morales F., Pearce R., Ord R., Leslie T., Rowland M., Gadalla N.B, et al. Multiple Origins of Mutations in the mdr1 Gene-A Putative Marker of Chloroquine Resistance in P. vivax. PLOS Neglected Tropical Diseases. 9(11), e0004196 (2015) doi: 10.1371/journal.pntd.0004196 SchousboeM.L. RanjitkarS. RajakarunaR.S. AmerasingheP.H. MoralesF. PearceR. OrdR. LeslieT. RowlandM. GadallaN.B Multiple Origins of Mutations in the mdr1 Gene-A Putative Marker of Chloroquine Resistance in P. vivax PLOS Neglected Tropical Diseases 9 11 e0004196 2015 10.1371/journal.pntd.0004196 Open DOI

109.Semedo M.G., Pereira A.L., Pita J.R.: The influence of German science on Cinchona and quinine research in Portugal in the second half of the 19th century. Pharmazie. 76(8), 396–402 (2021) doi: 10.1691/ph.2021.1050 SemedoM.G. PereiraA.L. PitaJ.R. The influence of German science on Cinchona and quinine research in Portugal in the second half of the 19th century Pharmazie 76 8 396 402 2021 10.1691/ph.2021.1050 Open DOI

110.Servián A., Helman E., Iglesias M. del R., Panti-May J.A., Zonta M.L., Navone G.T.: Prevalence of Human Intestinal Entamoeba spp. in the Americas: A Systematic Review and Meta-Analysis 1990–2022. Pathogens. 11(11), 1365 (2022) doi: 10.3390/pathogens11111365 ServiánA. HelmanE. IglesiasM. del R. Panti-MayJ.A. ZontaM.L. NavoneG.T. Prevalence of Human Intestinal Entamoeba spp. in the Americas: A Systematic Review and Meta-Analysis 1990–2022 Pathogens 11 11 1365 2022 10.3390/pathogens11111365 Open DOI

111.Sharpton T.J., Combrink L., Arnold H.K., Gaulke C.A., Kent M.: Harnessing the Gut Microbiome in the Fight against Anthelminthic Drug Resistance. Curr Opin Microbiol. 53, 26–34 (2020) doi: 10.1016/j.mib.2020.01.017 SharptonT.J. CombrinkL. ArnoldH.K. GaulkeC.A. KentM. Harnessing the Gut Microbiome in the Fight against Anthelminthic Drug Resistance Curr Opin Microbiol 53 26 34 2020 10.1016/j.mib.2020.01.017 Open DOI

112.Silva L.A., Reis-Cunha J.L., Bartholomeu D.C., Vítor R.W.A.: Genetic Polymorphisms and Phenotypic Profiles of Sulfadiazine-Resistant and Sensitive Toxoplasma gondii Isolates Obtained from Newborns with Congenital Toxoplasmosis in Minas Gerais, Brazil. PLOS ONE 12(1), e0170689 (2017) doi: 10.1371/journal.pone.0170689 SilvaL.A. Reis-CunhaJ.L. BartholomeuD.C. VítorR.W.A. Genetic Polymorphisms and Phenotypic Profiles of Sulfadiazine-Resistant and Sensitive Toxoplasma gondii Isolates Obtained from Newborns with Congenital Toxoplasmosis in Minas Gerais, Brazil PLOS ONE 12 1 e0170689 2017 10.1371/journal.pone.0170689 Open DOI

113.Singh A., Banerjee T., Shukla S.K., Upadhyay S., Verma A.: Creep in nitroimidazole inhibitory concentration among the Entamoeba histolytica isolates causing amoebic liver abscess and screening of andrographolide as a repurposing drug. Sci Rep. 13(1), 12192 (2023) doi: 10.1038/s41598-023-39382-1 SinghA. BanerjeeT. ShuklaS.K. UpadhyayS. VermaA. Creep in nitroimidazole inhibitory concentration among the Entamoeba histolytica isolates causing amoebic liver abscess and screening of andrographolide as a repurposing drug Sci Rep 13 1 12192 2023 10.1038/s41598-023-39382-1 Open DOI

114.Singh A., Houpt E., Petri W.A.: Rapid Diagnosis of Intestinal Parasitic Protozoa, with a Focus on Entamoeba histolytica. Interdisciplinary Perspectives on Infectious Diseases 2009(1), 547090 (2009) doi: 10.1155/2009/547090 SinghA. HouptE. PetriW.A. Rapid Diagnosis of Intestinal Parasitic Protozoa, with a Focus on Entamoeba histolytica Interdisciplinary Perspectives on Infectious Diseases 2009 1 547090 2009 10.1155/2009/547090 Open DOI

115.Sosa N., Pascale J.M., Jiménez A.I., Norwood J.A., Kreishman-Detrick M., Weina P.J., Lawrence K., McCarthy W.F., Adams R.C., Scott C., et al. Topical paromomycin for New World cutaneous leishmaniasis. PLoS Negl Trop Dis. 13(5), e0007253 (2019) doi: 10.1371/journal.pntd.0007253 SosaN. PascaleJ.M. JiménezA.I. NorwoodJ.A. Kreishman-DetrickM. WeinaP.J. LawrenceK. McCarthyW.F. AdamsR.C. ScottC. Topical paromomycin for New World cutaneous leishmaniasis PLoS Negl Trop Dis 13 5 e0007253 2019 10.1371/journal.pntd.0007253 Open DOI

116.Srivastava S., Mishra J., Gupta A.K., Singh A., Shankar P., Singh S.: Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India. Parasit Vectors. 10, 49 (2017) doi: 10.1186/s13071-017-1969-z SrivastavaS. MishraJ. GuptaA.K. SinghA. ShankarP. SinghS. Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India Parasit Vectors 10 49 2017 10.1186/s13071-017-1969-z Open DOI

117.Staines H.M., Burrow R., Teo B.H.Y., Chis Ster I., Kremsner P.G., Krishna S.: Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis. J Antimicrob Chemother. 73(3), 581–595 (2018) doi: 10.1093/jac/dkx431 StainesH.M. BurrowR. TeoB.H.Y. Chis SterI. KremsnerP.G. KrishnaS. Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis J Antimicrob Chemother 73 3 581 595 2018 10.1093/jac/dkx431 Open DOI

118.Steverding D.: The spreading of parasites by human migratory activities. Virulence. 11(1), 1177–1191 (2020) doi: 10.1080/21505594.2020.1809963 SteverdingD. The spreading of parasites by human migratory activities Virulence 11 1 1177 1191 2020 10.1080/21505594.2020.1809963 Open DOI

119.Takala-Harrison S., Jacob C.G., Arze C., Cummings M.P., Silva J.C., Dondorp A.M., Fukuda M.M., Hien T.T., Mayxay M., Noedl H., et al. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J Infect Dis. 211(5), 670–679 (2015) doi: 10.1093/infdis/jiu491 Takala-HarrisonS. JacobC.G. ArzeC. CummingsM.P. SilvaJ.C. DondorpA.M. FukudaM.M. HienT.T. MayxayM. NoedlH. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia J Infect Dis 211 5 670 679 2015 10.1093/infdis/jiu491 Open DOI

120.Tharmaratnam T., Kumanan T., Iskandar M.A., D’Urzo K., Gopee-Ramanan P., Loganathan M., Tabobondung T., Tabobondung T.A., Sivagurunathan S., Patel M., et al. Entamoeba histolytica and amoebic liver abscess in northern Sri Lanka: a public health problem. Trop Med Health. 48(1), 2 (2020) doi: 10.1186/s41182-020-0193-2 TharmaratnamT. KumananT. IskandarM.A. D’UrzoK. Gopee-RamananP. LoganathanM. TabobondungT. TabobondungT.A. SivagurunathanS. PatelM. Entamoeba histolytica and amoebic liver abscess in northern Sri Lanka: a public health problem Trop Med Health 48 1 2 2020 10.1186/s41182-020-0193-2 Open DOI

121.Tjitra E., Baker J., Suprianto S., Cheng Q., Anstey N.M.: Therapeutic Efficacies of Artesunate-Sulfadoxine-Pyrimethamine and Chloroquine-Sulfadoxine-Pyrimethamine in Vivax Malaria Pilot Studies: Relationship to Plasmodium vivax dhfr Mutations. Antimicrob Agents Chemother. 46(12), 3947–3953 (2002) doi: 10.1128/AAC.46.12.3947-3953.2002 TjitraE. BakerJ. SupriantoS. ChengQ. AnsteyN.M. Therapeutic Efficacies of Artesunate-Sulfadoxine-Pyrimethamine and Chloroquine-Sulfadoxine-Pyrimethamine in Vivax Malaria Pilot Studies: Relationship to Plasmodium vivax dhfr Mutations Antimicrob Agents Chemother 46 12 3947 3953 2002 10.1128/AAC.46.12.3947-3953.2002 Open DOI

122.Torgerson P.R. and Mastroiacovo P.: The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 91(7), 501–508 (2013) doi: 10.2471/BLT.12.111732 TorgersonP.R. MastroiacovoP. The global burden of congenital toxoplasmosis: a systematic review Bull World Health Organ 91 7 501 508 2013 10.2471/BLT.12.111732 Open DOI

123.Tripathi L.K., Nailwal T.K.: Chapter 1 – Leishmaniasis: an overview of evolution, classification, distribution, and historical aspects of parasite and its vector. In: Samant M, Chandra Pandey S, editors. Pathogenesis, Treatment and Prevention of Leishmaniasis. Academic Press. p. 1–25 (2021) https://www.sciencedirect.com/science/article/pii/B9780128228005000044 TripathiL.K. NailwalT.K. Chapter 1 – Leishmaniasis: an overview of evolution, classification, distribution, and historical aspects of parasite and its vector In: SamantM Chandra PandeyS editors Pathogenesis, Treatment and Prevention of Leishmaniasis Academic Press 1 25 2021 https://www.sciencedirect.com/science/article/pii/B9780128228005000044 Search in Google Scholar

124.Tse E.G., Korsik M., Todd M.H.: The past, present and future of antimalarial medicines. Malaria Journal. 18(1), 93 (2019) doi: 10.1186/s12936-019-2724-z TseE.G. KorsikM. ToddM.H. The past, present and future of antimalarial medicines Malaria Journal 18 1 93 2019 10.1186/s12936-019-2724-z Open DOI

125.Ungogo M.A., Campagnaro G.D., Alghamdi A.H., Natto M.J., de Koning H.P.: Differences in Transporters Rather than Drug argets Are the Principal Determinants of the Different Innate Sensitivities of Trypanosoma congolense and Trypanozoon Subgenus Trypanosomes to Diamidines and Melaminophenyl Arsenicals. International Journal of Molecular Sciences 23(5), 2844 (2022) doi: 10.3390/ijms23052844 UngogoM.A. CampagnaroG.D. AlghamdiA.H. NattoM.J. de KoningH.P. Differences in Transporters Rather than Drug argets Are the Principal Determinants of the Different Innate Sensitivities of Trypanosoma congolense and Trypanozoon Subgenus Trypanosomes to Diamidines and Melaminophenyl Arsenicals International Journal of Molecular Sciences 23 5 2844 2022 10.3390/ijms23052844 Open DOI

126.Waithera M.W., Sifuna M.W., Kimani S.K., Takei M.:. Drug selection pressure and fitness cost for artemether-resistant Plasmodium berghei ANKA parasites in vivo. International Journal of Antimicrobial Agents 62(6), 107012 (2023) doi: 10.1016/j.ijantimicag.2023.107012 WaitheraM.W. SifunaM.W. KimaniS.K. TakeiM. Drug selection pressure and fitness cost for artemether-resistant Plasmodium berghei ANKA parasites in vivo International Journal of Antimicrobial Agents 62 6 107012 2023 10.1016/j.ijantimicag.2023.107012 Open DOI

127.WHO. 2020. Sustained decline in sleeping sickness cases puts elimination within reach. [accessed 2024 Oct 4]. https://www.who.int/news/item/23-06-2020-sustained-decline-in-sleeping-sickness-cases-puts-elimination-within-reach. WHO 2020 Sustained decline in sleeping sickness cases puts elimination within reach [accessed 2024 Oct 4]. https://www.who.int/news/item/23-06-2020-sustained-decline-in-sleeping-sickness-cases-puts-elimination-within-reach Search in Google Scholar

128.Wicht K.J., Mok S., Fidock D.A.: Molecular Mechanisms of Drug Resistance in Plasmodium falciparum Malaria. Annual Review of Microbiology. 74, 431–454 (2020) doi: 10.1146/annurev-micro-020518-115546 WichtK.J. MokS. FidockD.A. Molecular Mechanisms of Drug Resistance in Plasmodium falciparum Malaria Annual Review of Microbiology. 74 431 454 2020 10.1146/annurev-micro-020518-115546 Open DOI

129.Wijnant G.J, Dumetz F., Dirkx L., Bulté D., Cuypers B., Van Bocxlaer K., Hendrickx S.: Tackling Drug Resistance and Other Causes of Treatment Failure in Leishmaniasis. Front Trop Dis. 3 (2022) doi: 10.3389/fitd.2022.837460 WijnantG.J DumetzF. DirkxL. BultéD. CuypersB. Van BocxlaerK. HendrickxS. Tackling Drug Resistance and Other Causes of Treatment Failure in Leishmaniasis Front Trop Dis 3 2022 10.3389/fitd.2022.837460 Open DOI

130.WHO. 2024a. Leishmaniasis. [accessed 2024 Aug 26]. https://www.who.int/news-room/fact-sheets/detail/leishmaniasis. WHO 2024a Leishmaniasis [accessed 2024 Aug 26]. https://www.who.int/news-room/fact-sheets/detail/leishmaniasis Search in Google Scholar

131.WHO. 2024b. Guidelines for the treatment of human African trypanosomiasis.[accessed 2024 Sep 3]. https://www.who.int/publications/i/item/9789240096035. WHO 2024b Guidelines for the treatment of human African trypanosomiasis [accessed 2024 Sep 3]. https://www.who.int/publications/i/item/9789240096035 Search in Google Scholar

132.WHO. 2023. World Malaria Report 2023. [accessed 2024 Aug 26]. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2023. WHO 2023 World Malaria Report 2023 [accessed 2024 Aug 26]. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2023 Search in Google Scholar

133.Xie S.C., Ralph S.A., Tilley L.:. K13, the Cytostome, and Artemisinin Resistance. Trends Parasitol. 36(6), 533–544 (2020) doi: 10.1016/j.pt.2020.03.006 XieS.C. RalphS.A. TilleyL. K13, the Cytostome, and Artemisinin Resistance Trends Parasitol 36 6 533 544 2020 10.1016/j.pt.2020.03.006 Open DOI

134.Yoshida N., Yamauchi M., Morikawa R., Hombhanje F., Mita T.: Increase in the proportion of Plasmodium falciparum with kelch13 C580Y mutation and decline in pfcrt and pfmdr1 mutant alleles in Papua New Guinea. Malar J. 20(1), 410 (2021) doi: 10.1186/s12936-021-03933-6 YoshidaN. YamauchiM. MorikawaR. HombhanjeF. MitaT. Increase in the proportion of Plasmodium falciparum with kelch13 C580Y mutation and decline in pfcrt and pfmdr1 mutant alleles in Papua New Guinea Malar J 20 1 410 2021 10.1186/s12936-021-03933-6 Open DOI

135.Zajaczkowski P., Lee R., Fletcher-Lartey S.M., Alexander K., Mahimbo A., Stark D., Ellis J.T.: The controversies surrounding Giardia intestinalis assemblages A and B. Current Research in Parasitology & Vector­Borne Diseases 1, 100055 (2021) doi: 10.1016/j.crpvbd.2021.100055 ZajaczkowskiP. LeeR. Fletcher-LarteyS.M. AlexanderK. MahimboA. StarkD. EllisJ.T. The controversies surrounding Giardia intestinalis assemblages A and B Current Research in Parasitology & Vector­Borne Diseases 1 100055 2021 10.1016/j.crpvbd.2021.100055 Open DOI

136.Zoltner M., Campagnaro G.D., Taleva G., Burrell A., Cerone M., Leung K.F., Achcar F., Horn D., Vaughan S., Gadelha C., et al. Suramin exposure alters cellular metabolism and mitochondrial energy production in African trypanosomes. Journal of Biological Chemistry. 295(24), 8331–8347 (2020) doi: 10.1074/jbc.RA120.012355 ZoltnerM. CampagnaroG.D. TalevaG. BurrellA. CeroneM. LeungK.F. AchcarF. HornD. VaughanS. GadelhaC. Suramin exposure alters cellular metabolism and mitochondrial energy production in African trypanosomes Journal of Biological Chemistry 295 24 8331 8347 2020 10.1074/jbc.RA120.012355 Open DOI